BGM

distress 0/10 · well-funded / low risk

$0.27-3%today-98% from 52w high

bgmgroupltd.comChengdu, ChinaDrug Manufacturers - Specialty & Generic

Revenue

$14M

Liquidity

$14M

Runway

—

Shares 1y

+19%

Price & events

-92.9% over 6M

CatalystRating changeDilutionFinancingdashed = today

-2.8%

-6.5%

-20.2%

-16.8%

-92.7%

-97.2%

-95.2%

-98.6%

-99.4%

All

Overview

Market Cap: $9.76M
Volume: 3.59K
52 Week Range: $0.26 – $11.75
Total Shares: 35.75M
Short %: 0.06%
% Held by Insiders: 23.83%
% Held by Institutions: 0.06%
RVOL: 0.01x

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 35,750,000 · 0 offerings/1y · 0 PIPEs

2025-04-02EFFECTshelf_effective
2025-03-07F-3shelf_registration
2024-12-03SC 13Dstrategic_stake
2024-11-29SC 13D/Astrategic_stake
2024-11-22EFFECTshelf_effective
2024-11-05F-3shelf_registration
2024-10-16SC 13Dstrategic_stake

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified